Market Cap $32.14M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
NOX | Ann: US company demonstrates strong Sofra potential | 07:30 | 7 | 1.6K | |||
|
|||||||
NOX | Ann: June 2025 Quarterly Activities Report and Appendix 4C | 04/08/25 | 4 | 1.3K | |||
|
|||||||
NOX | Ann: HERACLES clinical trial - Update 1 | 29/07/25 | 5 | 2.2K | |||
|
|||||||
NOX | Ann: First SOF-SKN dose in HERACLES clinical trial | 21/07/25 | 3 | 1.9K | |||
|
|||||||
NOX | Noxopharm gets HERACLES autoimmune trials started with first human doses | 16/07/25 | 0 | 310 | |||
|
|||||||
NOX | Ann: Clinical trial recruitment progressing rapidly | 11/07/25 | 9 | 3.5K | |||
|
|||||||
NOX | Ann: Promising Sofra results from overseas company | 24/06/25 | 19 | 6.1K | |||
|
|||||||
NOX | Ann: Green light for HERACLES clinical trial | 10/06/25 | 4 | 1.8K | |||
|
See All Discussions
Timeline
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
![]() |
|
||||
View More |